We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

48 hedge funds and large institutions have $155M invested in T2 Biosystems, Inc in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

0% more funds holding

Funds holding: 4848 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

15% less capital invested

Capital invested by funds: $182M → $155M (-$27.7M)

Holders
48
Holders Change
Holders Change %
0%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
5
Increased
18
Reduced
10
Closed
4
Calls
$84K
Puts
Net Calls
+$84K
Net Calls Change
+$84K

TTOO Hedge Fund Activity: Q2 2016 in Review

48 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2016, worth a combined $155M — down 15% from $182M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TTOO positions and 4 closed out — a net gain of 1 holder — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Tiger Management, adding an estimated $6.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $3.33M sold.

  • 48 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $155M of T2 Biosystems, Inc stock for Q2 2016, down 15% quarter-over-quarter.
  • 5 funds opened new T2 Biosystems, Inc positions in Q2 2016 and 4 closed out, a net change of +1 holder.
  • The largest T2 Biosystems, Inc buyer in Q2 2016 was Tiger Management, an estimated $6.27M added.
  • The largest T2 Biosystems, Inc seller in Q2 2016 was T. Rowe Price Associates, an estimated $3.33M sold.

Based on aggregated 13F filings for Q2 2016.